DOCN - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 55/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.7x as much as the broader market.

Beta (Market Relation)

1.7x

Above average

Volatility (5Y p.a.)

72.3% p.a.

5-Year Horizon

Max Drawdown (5Y)

-84.8%

5-Year Horizon

Sharpe Ratio

0.08

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+227.4%
3 Years	69.3%	-44.9%	1.04	+74.5%
5 Years	72.3%	-84.8%	0.08	+8.1%
10 Years	—	—	—	—

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 213%.

High market risk: Beta of 1.70 indicates above-average volatility compared to the broader market.

🔴 High valuation risk: Avg P/E of 62.1 (Elevated multiple compression risk)

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (72.3% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -84.8% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

8 ISS Score: 8 / 10

Audit Risk

2 ISS Score: 2 / 10

Board Risk

9 ISS Score: 9 / 10

Short Ratio

3.70